Several human genetic syndromes related to DDR components.
1.1. Types and sources of DNA damage
During our lifetime, the genome is constantly being exposed to different types of damage caused either by exogenous sources (radiations and/or genotoxic compound) but also as byproducts of endogenous processes (reactive oxigen species during respiration, stalled forks during replication, eroded telomeres, etc).
From a structural point of view, there are many types of DNA damage including single or double strand breaks, base modifications and losses or base-pair mismatches. The amount of lesions that we face is enormous with estimates suggesting that each of our 1013 cells has to deal with around 10.000 lesions per day . While the majority of these events are properly resolved by specialized mechanisms, a deficient response to DNA damage, and particularly to DSB, harbors a serious threat to human health .
DSB can be formed  following an exposure to ionizing radiation (X- or γ-rays) or clastogenic drugs;  endogenously, during DNA replication, or , as a consequence of reactive oxygen species (ROS) generated during oxidative metabolism. In addition, programmed DSB are used as repair intermediates during V(D)J and Class-Switch recombination (CSR) in lymphocytes , or during meiotic recombination . Because of this, immunodeficiency and/or sterility problems are frequently associated with DDR-related pathologies.
2. DNA repair of DSB. NHEJ and HR
Mammalian cells are equipped with two mechanisms that repair DSB and prevent dangerous chromosomal rearrangements; 
2.1. Non Homologous End Joining (NHEJ)
NHEJ is simpler and faster than HR, and can take place in any cell cycle stage. However, NHEJ can process altered or improper ends is thus more error-prone that HR. Therefore, HR is the preferred repair mechanisms during S/G2 phases. However, due to the preponderance of the G0/G1 stage, NHEJ is key to safeguard genomic integrity in mammalian organisms. Moreover, and probably due to the larger genomes and abundant repetitive sequences which limit HR proficiency, mammalian genomes are also frequently healed by NHEJ in S/G2 .
The mechanism by which NHEJ rejoins a DSB is fairly understood. First, DSB are recognized by a heterodimer formed by Ku70 and Ku80 proteins . Ku proteins display a ring-like structure and are able to bind and stabilize the ends of DSB, acting as sensors, and subsequently attracting the transducer kinase, DNA-PK (DNA dependent protein Kinase). DNA-PK is a large Ser/Thr kinase (about 470 Kda), which belongs to the PIKK family (PI3-kinase like family of protein kinases). Other members of this family, ATM (ataxia talangectasia mutated) and ATR (ATM and RAD3-related), are key kinases in the DDR and will be explained in futher detail below. Once DNA-PK is located to the DSB it becomes activated and phosphorylates several substrates involved in the processing and ligation of DNA ends. Significantly, DNA-PK can also auto-phosphorylate in several residues, which seems to be essential for its repair capacity .
Finally, the main effectors of NHEJ form a multimeric complex (DNA Ligase IV-XRCC4-XLF), which is recruited to DSB and activated by DNA-PK dependent phosphorylation. This complex is responsible for the actual rejoining of the ends . Ligase IV provides the catalytic activity for the rejoining, while XRCC4 stabilizes and stimulates its activity .
Ku70 and Ku 80 (sensors), DNA-PK (transducer) and DNA ligase IV and XRCC4 (effectors) are the core component of NHEJ. But often other accessory components are required for the conversion of altered broken ends. For instance, DSB produced by IR usually requires an end-processing step prior to relegation, such as the one regulated by Artemis, a 5’- 3’ exonuclease, that acquires endonuclease activity when phosphorylated by DNA-PK . This activity of Artemis is important to open closed hairpins in which the two strands of the DSB have linked together. Importantly, such hairpins are normally generated at the DSB generated by RAG nucleases during V(D)J recombination. Note that ATM can also induce the phosphorylation and activation of Artemis . In fact, and in addition to be important for the repair of accidental DSB, NHEJ carries out several specialized functions in lymphocytes during V(D)J and CSR [12, 13]. Accordingly, patients with mutation in Artemis, ATM or DNA-PKcs, as well as in other NHEJ components, often suffer from immune deficiencies as well as from an increased predisposition to cancer .
Another context in which difficult-to repair DSB are formed relates to chromatin accessibility. For instance, it is estimated that around 10% of radiation induced DSB are repaired with slow kinetics, this population being enriched adjacent to compacted chromatin (heterochromatin). In this case, ATM and not DNAPK will play an important role in the NHEJ-mediated repair of these difficult-to-repair breaks. In this context, ATM activation is necessary to phosphorylate some substrates like H2AX or KAP1, which would relax chromatin compaction allowing the access of repair proteins to DSB at heterochromatin [11, 15]. Nevertheless, it should be noted that the main cell-type that suffers from ATM deficiency is Purkinje cells which are almost devoid of heterochromatin, so that ATM must play additional roles in euchromatin .
2.2. Homologous recombination
The other mechanism that cells use for DSB repair, and the most important for replicating cells, is Homologous Recombination. In contrast to NHEJ, during HR DSB need to be first extensively processed to allow for the search of the homologous undamaged template. First, ends undergo 5’-3´ resection producing two single stranded DNA regions. Rad51-coated ssDNA stretches invade the sister chromatid DNA duplex forming inter-strand structures. How these heteroduplexes are finally resolved is still not fully characterized.
Since HR repairs DSB using the sister chromatid as template, it is restricted to S and G2 phases. Restricting HR in G1 is in fact critical, since if HR takes place in G1 it could lead to loss of heterozigosity (LOH) or chromosomal translocations . To avoid this problem the activity of several HR components is regulated by several S-G2 specific CDKs (cyclin dependent kinases) .
For teaching purposes, and trying to simplify the complex process that takes place during HR, we will artificially divide it in 4 independent stages. We acknowledge that many of the stepwise events described here are still to be fully validated, but just want to transmit a holistic view of how a DSB can be sensed, signaled and repaired by HR:
The Mre11-Rad50-Nbs1 (MRN) complex is one of the first in being recruited to DSB . Next, through a direct interaction, MRN recruits ATM which, among other things, phophorylates H2AX (a variant of the canonical histone H2A) at serine 139, forming γH2AX . Direct phospho-binding to γH2AX recruits the adaptor protein MDC1 , which through interaction with ATM and Nbs1 forms a positive feedback loop that amplifies the γH2AX signal . In addition, ATM-dependent phosphorylation of MDC1 is recognized by the E3 ubiquitin ligase RNF8, that ubiquitinates histones in the vicinity of the DSB [23, 24]. Another E3 ubiquitin ligase, RNF168 (mutated in the human RIDDLE immunodeficiency syndrome), is also recruited and amplifies the ubquitylation signal, in both cases mediated by UBC13 E2 ligase, eventually recruiting 53BP1 and BRCA1 to DSB-associated foci [25-27]. In the case of BRCA1, RAP80 binds to ubiquinylated substrates at DSB through its UIM (Ubiquitin Interaction Motif) . RAP80 then interacts with Abraxas , the deubiquitylating (DUB) enzyme BRCC36 and BRCA1 (breast cancer 1, early onset). BRCA1 is a well known human breast cancer susceptibility gene, responsible for the third part of familiar breast cancer . BRCA1 is a large protein (over 200 kDa) that is constitutively bound to BARD1. Together, BRCA1/BARD1 present E3 ubiquitin ligase activity . Although BRCA1 has been the subject of many studies and it is known to participate in HR, its exact role(s) and whether its ubiquitin ligase activity is critical for its activity is still not well understood. Whereas the road from DSB to BRCA1 is more understood, how 53BP1 is loaded to substrates modified by RNF8/RNF168 remains unknown.
Importantly, it should be noted that all of these events have been inferred from the formation or absence of
As mentioned before, the resection of the two 5’ ends of the DSB is an essential step for HR. Three exonucleases (Mre11, Exo1 and CtIP) and one helicase (BLM) have been involved in resection [32-34]. Importantly, ATM dependent phosphorylation seems to stimulate CtIP-mediated resection, linking DNA damage signaling with the processing of DNA ends . In addition to ATM, ssDNA is quickly coated by RPA (replication protein A) and triggers a parallel pathway resulting in the activation of the kinase ATR [18, 36-38], that will be described below. It remains to be seen to what extent ATM, ATR, and perhaps DNA-PK collaborate in the processing of DSB for HR. One important recent development is the finding that, against all expectations, 53BP1 might limit resection . This would explain how the absence of 53BP1 rescues the cancer and ageing phenotypes of a BRCA1 mutant mouse model, which could be explained by an improved HR through enhanced resection .
The initiation of recombination requires the loading of the recombinase Rad51, which replaces RPA coating on the ssDNA. Rad51, a protein with DNA-dependent ATPase activity, together with other associated proteins (DSS1, RAD52,RAD51B, RAD51C, RAD51D, XRCC2, XRCC3, RAD54, etc.) form a nucleoprotein filament that mediates strand invasion of the sister chromatid . In mammals, Rad51 loading is mediated by BRAC2 . Once again, BRCA2 is another important breast cancer susceptibility gene suggesting a critical role of HR in the prevention of breast cancer . In contrast to BRCA1, BRCA2 recruitment to DSB is not fully understood, one possible scenario being that BRCA1 could mediate the recruitment of FancD2 and BRCA2 to DSB .
The nucleoprotein filament (ssDNA, RAD51 and other HR proteins) searches for an homologous region within the duplex DNA in the sister chromatid and displaces a DNA strand forming a D-loop structure and the 3’ end of the invading strand. This invading end then is extended by un unknown DNA polymerase (
If HJ formation was remained elusive, the resolution of Holliday junctions is even a bigger mistery, many proteins having been proposed as candidates to be the HJ “resolvase”. Such a protein should have helicase and nuclease activities, like BLM (Bloom syndrome protein), MUS81-EME1 complex or GEN1 [48-51]. All of them have been proposed to be the missing HJ-resolvase at some point. Moreover, recent evidence suggests that another enzyme, SLX4, could be such missing link [52, 53]. Whereas it seems clear that many proteins can deal with HJ-resembling structures
In addition to its role at DSB, HR also has a key role in restarting stalled replication forks (RF). SSBs, interstrand crosslinks or other lesions in the DNA promote stalling of the RF which, if persistent, could lead to breakage that has to be resolved by HR . ATR, another PIKK kinase that is essential for an appropriate progression of RF, may be regulating HR in this case. In fact, ATR and its target kinase Chk1 phosphorylate a number of HR-related proteins such as BRCA1, BLM and Rad51 [55-57].
HR also participates in the maintenance of telomere length, by promoting inter-telomeric HR in the absence of telomerase. This pathway is known as alternative lengthening of telomeres (ALT) . Finally, HR is the repair pathway of the recombination reaction that occurs between homologous chromosomes in meiosis, where DSB are intentionally generated in order to increase genetic variability.
Whereas we here provided a simplified view of DSB repair, it should be noted that other still poorly understood pathways of repair such as micro-homology directed NHEJ, which joins partially resected DSB, are emerging as important genome caretakers.
3. Signaling DSB
We here present a general view of how cells signal DSB, with a particular emphasis on phosphorylation, which is the most known mechanism to date.
3.1. Phosphorylation. The so-called DNA Damage Response (DDR)
The so-called DDR stands for a coordinated signaling response which starts at the DSB and which promotes DNA Repair while it limits the expansion of the damaged cell by apoptotic or cytostatic mechanisms. The canonical DDR begins with the activation of two PIKK, ATM and ATR, upon detection of DSB. The role of DNA-PK, another member of the PIKK family, is mainly to stimulate repair activities locally at the break but without triggering a cellular response. Thus, ATM and ATR are considered the main upstream kinases in the signaling of DNA damage. Whereas they are activated by different types of damage and have some specific substrates and functions, their “response” is frequently interconnected. The activation of any of these kinases starts a phosphorylation cascade leading to cell cycle arrest (
In the last decade the knowledge about the DDR has substantially increased, and besides the classical activation of the PIKK and phosphorylation cascades, other types of signaling such as ubiquitylation or sumoylation have burst . A general overview of this complex pathway will be explained below.
3.1.1. Central players of the DDR: PIKK kinases: ATM, ATR and DNA-PK
The DDR has a well defined hierarchy. Their components have been classified into sensors, transducers, mediators and effectors. ATM and ATR kinases are considered the main DDR transducers.
As mentioned, ATM, ATR and DNA-PK belong to the PIKK (phosphatidylinositol-3-kinase related kinases) family . They are large proteins (more than 300 kDa) with similar structure: a variable number of repeat domains in the N-terminus (HEAT domains), a FAT domain, a catalytic domain homologue to that in PI-3-Kinase (PI3K), a PIKK regulatory domain (PRD) and a FATC domain at the very C-terminus . The PRD domain has been shown to mediate kinase activation, at least for ATR; and HEAT, FAT and FATC domains may be involved in the specific interactions of these proteins with their substrates and modulators .
ATM, ATR and DNA-PK specifically phosphorylate serine and threonine residues frequently followed by a glutamine. Upon activation, they are able to phosphorylate hundreds of common substrates regulating many cellular functions . Noteworthy, some of them are preferred by one specific kinase, which is likely due to mediators. For instance, whereas all three can phosphorylate H2AX, Chk1 is only phosphorylated by ATR and this is explained by the need of Claspin in mediating the ATR/Chk1 interaction.
Despite their similarities, these kinases play different roles in the DDR. In brief, DNA-PK is activated in response to DSB and promotes their repair by NHEJ. However, if DSB are located in heterochromatin or they are too numerous, ATM activates additional repair mechanism (e.g. HR) and starts checkpoints signaling. In addition, ATR is activated by ssDNA, generated when DSB persist and are ressected into ssDNA, or when a replication fork is collapsed, promoting a strong checkpoint signaling. Besides, whereas ATM and DNA-PK are active through all the cell cycle, ATR activity is confined only to S and G2 phases . One possible scenario is that the activity of the three kinases follows a stepwise activation if a DSB persist. This model is explained below.
a. DNA-PK. Stimulation of DNA Repair
The first step in this model will be the immediate activation of DNA-PK at a DSB. Previously in this chapter, we described how DNA-PK is activated and promotes NHEJ. In summary, the dimer Ku70/Ku80 binds and stabilizes the DSB ends, it recruits DNA-PK that activates the NHEJ effectors, LigaseIV-XRCC4-XLF. Thus, DNA-PK will provide a fast repair mechanism for easy-to-repair breaks, without the activation of checkpoint activities. It must be emphasized again, that DNA-PK has a very limited role in checkpoint signaling. However in the absence of ATM, DNA-PK may stay longer at the DSB and contribute to checkpoint functions .
b. ATM. DSB sensing and ATM Activation
If the DSB persist, one plausible scenario is that ATM could phosphorylate and displace DNA-PK from the DSB, so that repair and checkpoint activities are implemented. ATM is the most studied and likely best known DDR kinase. One reason for this is that its absence is responsible for the human Ataxia-Telangiectasia (A-T) hereditary disorder . A-T is a severe autosomal recessive disease characterized by early onset progressive cerebellar ataxia, oculocutaneous telangectasia, immunodeficiency and lymphoid tumours . Immunodeficiency and predisposition to lymphoid tumours is explained by the role of ATM during T and B lymphocyte development, where DSB are generated as by-products of immune rearrangements. Besides, cells of these patients present numerous breaks, what explains their increase predisposition also to other cancer types.
Whereas it seems clear that the main role of ATM is related to the DDR , the two symptoms that named the disease, ataxia and telangiectasia, are still not explained by the role of ATM in relation to DNA damage, suggesting that ATM may have other functions not related to DSB-signaling. Moreover, even though we have significant understanding of the effects of ATM activation, how this is accomplished is still a matter of debate.
As described above, ATM activation is triggered by the recruitment of the MRN complex (sensor) in response to DSB (Figure 2). MRN complex recruits ATM and collaborates for its activation . However, the precise mechanism by which ATM becomes activated is still a matter of controversy . Some authors claimed that, in basal conditions, ATM is an inactive homodimer which undergoes dissociation and activation in response to DSB, due to its autophosphorylation . Importantly, it has later been shown that ATM autophosphorylation is not necessary for its activation
Nbs1, part of the MRN complex, could contribute to ATM phosphorylation and activation , and several other proteins, such as the histone acetyl transferase Tip60 , have been reported to be involved in ATM activation.
ATM has been claimed to be activated by other stimuli rather than DNA damage, like chloroquine or osmotic shock . However, whether those stimuli do not generate damage, particularly during replication, remains to be seen. There are some evidences of a cytoplasmic fraction of ATM that might be helpful to explain part of the symptoms of A-T disease not related to the DDR like the early neurodegeneration. Of note, ATM in neuronal cells has been found predominantly cytosolic .
c. ATR. Activation by ssDNA
The last (in fact, its activation occurs later than ATM) main PIKK kinase in the signaling of DSB is ATR. As noted before, despite their homology, ATR responds to different types of stresses than ATM does, and although these two kinases share several substrates, ATR regulates different processes. ATR has an essential role during replication, sensing alterations in fork progression and activating cellular checkpoints if necessary [79, 80].
In contrast to ATM, ATR is essential at the organism and the cellular level . Consequently there is not any human disease lacking ATR. However, patients of a very rare ATR-related disease known as the Seckel syndrome are alive with very low amounts of ATR .
The input for ATR is not the DSB itself, but rather unusual large strands of ssDNA that can be generated in several circumstances :
In contrast to ATM, the molecular mechanism of ATR activation by ssDNA is well established (Figure 2). RPA-coated ssDNA  recruits the ATR-ATRIP (ATR interacting protein) complex . At the same time, Rad17 and subsequently the 9-1-1 (Rad9-Rad1-Hus1] complex are also brought to the damage sites by RPA . The 9-1-1 complex, with a PCNA-like clamp conformation, then brings the allosteric activator TopBP1 (topoisomerase-binding protein 1] into close proximity of ATR . The interaction of ATR with TopBP1 is then sufficient to unleash ATR activity . Of note, activation of ATR by TopBP1 even in the absence of DNA breaks is sufficient to promote a robust cellular response including senescence, demonstrating the key role of the DDR in responding to DNA damage .
3.1.2. Mediators and DDR amplification. Foci forming factors
Downstream of the PIKK, DDR signaling is amplified by several mechanisms, allowing the response to achieve its final cellular outcomes. On one hand, the DDR, like any other phosphorylation cascade, amplifies its signal in subsequent (enzymatic) step. This involves the participation of
Once ATM or DNA-PK are activated, the rapid phosphorylation of the histone H2AX (
Among the different factors, 53BP1 is probably one of the most studied examples of an IRIF forming protein. 53BP1 has a pan-nuclear location which, after exposure to genotoxic agents, is quickly repositioned to IRIF. 53BP1 localization into foci is dependent on several upstream events including H2AX phosphorylation , recruitment of MDC1, ubiquitinating activity of RNF8 and RNF168 [23, 25, 92, 93], and methylation of histones H3 and H4 [94, 95]. Regardless of their importance for our understanding of the DDR, the absence of foci does not seem to be essential for a proficient DDR. Thus, mouse models lacking H2AX or MDC1, that abolishes IRIF formation, as well as 53BP1 null mice, are viable, but they exhibit phenotypes related to DDR deficiency like genome instability, cancer predisposition or immunodeficiency [22, 96, 97]. In summary, while not essential, IRIF seem to modulate the amplitude of the signaling of DSB which might be important in conditions of low numbers of DSB.
In contrast to ATM, ATR does not undergo any post-translational modifications which would modify its activity, such as autophosphorylation. Nevertheless, a number of mediators of ATR signaling are indeed regulated through phosphorylation. For instance, the ATR activator TopBP1 is phosphorylated by ATM at resected DSB ; and probably also by ATR in response to RS. In addition, Claspin phosphorylation is also required for ATR-dependent phosphorylation of Chk1 in response to DSB .
In summary, ATM and ATR signaling are amplified and driven by these and many other mediators. The endpoint of the signaling cascade arrives with the activation of the effectors, which would finally be responsible for the cellular responses.
3.1.3. Effectors and cellular outcomes of the DDR
In addition to promote the repair of DNA lesions, the DDR can orchestrate multiple cellular responses orientated to safeguard genome integrity or, in some cases, to avoid transmission of harmful alterations by activating apoptosis or senescence. In this context, one of the main effectors of the DDR is the transcription factor p53 which provides a late sustained response to DNA damage. p53 up-regulation contributes to the activation of checkpoints, and, if the damage persists, may activate senescence, apoptosis or cell differentiation programmes.
Regardless of this p53-centric view, it is clear that many p53-independent pathways are also stimulated by the DDR. For instance, a single proteomic study identified more than 700 ATM/ATR phosphorylation substrates, pointing out the wide variety of effectors and pathways that are regulated by the DDR .
Given that there are multiple reviews elsewhere that focus on these cellular responses, we here only briefly describe the main cellular responses promoted by the DDR: cell cycle checkpoints, senescence, apoptosis and differentiation.
184.108.40.206. Transient cell cycle delay: Checkpoints
The transitions through the different stages of the cell cycle are tightly regulated by the activity of cyclin-dependent kinases (CDKs). CDKs are activated by cyclins and inhibited by CDK inhibitors (CKIs) or inhibitory tyrosine phosphorylations . In brief, a simplified scheme depicts that four CDKs are involved in the regulation of cell cycle; CDK2, CDK4 and CDK6 during interphase, and CDK1 being considered the mitotic CDK. An activated DDR can limit the activity of CDKs and thus prevent cell cycle progression into the next stage (G1/S and the G2/M). In addition, the DDR can also slow down replication (intra-S checkpoint), but this is not a full stop and cells with damage in S-phase progress into G2 stop at the G2/M checkpoint . The way that the DDR gets to the CDKs is through effectors that limit CDK activity which we now briefly summarize.
First, the main PIKK targets that regulate checkpoints are the so-called checkpoint kinases Chk1 and Chk2, direct substrates of ATR and ATM respectively [102, 103]. Checkpoint kinases act by regulating CDK inhibitory effectors such as Cdc25a, Wee1 or p53.
If damage arises in S phase, the
The last key control point is the
220.127.116.11. Permanent cell cycle arrest: Senescence
By definition, checkpoints are a transitory state from which cells can escape if repair is accomplished and the signal is turned off. In contrast, cellular senescence is a persistent and irreversible cell cycle arrest. It was firstly observed in cell culture in 1965 . Depending on the load of DNA damage or the cell type, a persistent activation of the DDR might direct cells into senescence .
Besides the presence of DSB, other cellular stresses can also promote senescence. These include telomere shortening , oxidative stress  and oncogenes [118-121]. Nevertheless, all of these stimuli can activate the DDR, so that DNA damage might be the ultimate cause of the senescent response. First, short or unprotected telomeres resemble and are actually sensed by cell as DSB [122, 123]. Second, reactive oxygen species generated by oxidative stress are an obvious source of DNA damage. Finally, several oncogenes have been shown to induce RS so that oncogene-induced senescence (OIS) would be linked to the DDR [124-126]. Importantly, and as it will be discussed below, OIS has been suggested as an early anti-cancer barrier in vivo, providing a link between the DDR and cancer development . However, it must be pointed out that alternative, DDR-independent pathways of promoting OIS and which operate through the Ink4a/ARF locus have been described .
Apoptosis, or programmed cell death, is other phenomenon activated by the DDR in order to eliminate cells with intolerable amounts of DNA damage. As such, apoptosis has an important role in eliminating damaged cells during aging  or in the acute responses genotoxic cancer therapies. In addition, apoptosis is a physiological process essential for normal development.
As in the case of senescence, apoptosis is also chiefly governed by p53. DDR-induced p53 promotes the expression of several pro-apoptotic factors, such as Puma, Noxa and Bax [130-132]. This pro-apoptotic p53 program leads to mitochondrial membrane permeabilzation , allowing the exit of cytochrome c to the cytosol, forming the apoptosome, which finally activates effector caspases .
Why some cells undergo apoptosis and other senescence in response to DNA damage is still a matter of study . Although most cells are capable of both phenomenons, cell type is indeed determinant to undergo one or another. For instance, whereas DNA damage in fibroblasts and epithelial cells specially promotes senescence, low amounts of DNA breaks in lymphocytes are sufficient to trigger apoptosis. Of note, post-mitotic cells like neurons, have a limited capacity to become senescent or undergo apoptosis which might be due to their particular cell cycle status.
18.104.22.168. Other cellular pathways stimulated by the DDR
Given the large amount of PIKK phospho-targets and p53 transcriptional targets it is not surprising that the DDR exerts its function in many cellular processes by means that remain poorly understood. For instance, high doses of DNA damage can induce the
Finally, another process that might be modulated by DNA damage is
3.1.4. Physiological consequences of the DDR
DDR deficiencies cause important physiological consequences. As commented on this chapter, DSB are physiologically generated during B and T lymphocyte maturation and during meiotic recombination, and many DDR-related proteins are required for normal functioning of these processes. In addition, the DDR has an essential role in facing the stochastic DNA damage that our cells acquire through our lifetimes. In this context, it is not surprising that deficiencies in DDR components cause human diseases associated to immune deficiencies, sterility, premature aging and cancer predisposition. Alterations during embryonic development are also frequent, suggesting that the high division rates occurring at this stage might be prone to accumulate DNA damage, particularly RS.
DDR-mutant mouse models recapitulate many of the phenotypes found in DDR-associated human syndromes. Some of the most relevant DDR-related diseases are shown in table 1. Most of them are of recessive nature, with some exceptions such as variants of Li-Fraumeni, which can be caused by dominant mutations in just one allele of p53.
|ATM||Cerebellar ataxia, telangiectasia, inmunodeficiency, lymphoid tumours.|
|Nbs1||Growth retardation, microcephaly, immunodeficiency, lymphoid tumours.|
|Mre11||Cerebellar ataxia, mild predisposition to tumours.|
|ATR||Progeria, microcephaly and other developmental defects.|
|p53||Early development of cancer (breast cancer, sarcomas, brain tumours, leukemias, etc.)|
|RNF168||Inmunodeficiency, dysmorphic features, mental retardation.|
|RECQL2 (WRN)||Progeria and age-associated disorders|
|13 different FA genes||Bone marrow failure, predisposition to leukemias and solid tumours.|
22.214.171.124. The DDR and cancer: Protector and target
The relationship between the DDR and cancer is of particular interest from multiple points of view. First, the DDR is critical to prevent the accumulation of spontaneous pro-cancerous mutations and overall genomic instability. This is why most DDR-related human diseases are prone to cancer development. In addition, the DDR is particularly relevant in preventing chromosome rearrangements during lymphoid maturation which makes lymphomas one of the most frequent cancer in Genomic Instability Syndromes. Note that in some cases mutations in only one allele convey a dramatic increase in cancer predisposition. This is the case for BRCA1 and BRCA2 mutations carriers, whose life-time breast cancer risk raise up to 80%.
Second, the DDR is activated by oncogenes in early stages of tumorigenesis [124, 141]. These studies proposed a model where the activation of certain oncogenes could generate RS which, by activating the DDR, would limit cancer development by promoting cell senescence [142, 143]. In fact, convincing evidence exists to show that certain oncogenes indeed are able to generate DNA damage trough promoting abnormal replication [124, 125]. Note that this type of damage, known as RS, is sensed and signaled mainly by ATR rather than ATM , raising the relevance of ATR-signaling in the oncogene-activated DDR model of cancer progression.
Finally, many of the current anti-cancer therapies (including radiotherapy) operate by generating high loads of DNA damage that activate the DDR towards apoptosis. In this regard, there is increasing interest in the development of new anti-cancer strategies that take advantage of our knowledge of the DDR to specifically target tumor cells. The idea behind these new strategies is to exploit synthetic lethal interactions that will only occur in cancer cells. For instance, one of the most promising approaches in this regard is the use of
126.96.36.199. The role of the DDR in ageing
Ageing is intuitively associated with the natural degeneration of our tissues, which would derive from the accumulation of some “toxic” factor. Studies mostly performed in the last decade have identified DNA damage as this deleterious factor that is associated to the onset of ageing [149, 150]. For instance, aged tissues or stem cells show evidences of an activated DDR [151, 152]. Moreover, most DDR-related genetic diseases suffer from premature ageing, which is likely due to a faster accumulation of intolerable amounts of DNA damage.
The most accepted theory is that DNA damage, when accumulated in SC, activates a DDR that limits their regenerative capacity and thus promotes ageing [151, 153]. To what extent DNA damage is the natural cause of actual ageing in humans, and which types of DNA damage (RS, eroded telomeres, ROS…) are most important in this process, remains to be understood. In what regards to RS, the faster nature of embryonic cell divisions might make this stage particularly susceptible to this type of damage. In fact, recent studies in ATR hypomorphic mice revealed that an intra-uterine exposure to RS can accelerate the later onset ageing [146, 154]. Whereas the exact mechanism of this intrauterine programming of ageing is not fully understood, it raises the question about to what extent our adult well-being can be already conditioned by the stresses to which we were exposed
3.2. Other posttranslational modifications in the DDR
There is little doubt that PIKK-mediated phosphorylation is a major controller of the DDR. Nevertheless, to end this chapter we would want to describe the role that non-phosphorylation based signaling of DNA damage might play in genome protection. In the light of recent discoveries, DNA damage signaling through other PTMs such as acetylation, methylation, ubiquitination and, sumoylation might also play crucial roles for appropriate DNA damage signaling.
Ubiquitination is a highly regulated process that promotes covalent modification of specific proteins substrates with the 76-amino acid protein
UQ presents seven lysines in its surface: K6, K11, K27, K29, K33, K48 and K63. Whereas poly-ubiquitination linked to K48 residues is usually related to proteasomal degradation , K63-linked polyubiquitin chains are more related to other regulatory functions . In addition to the conjugating lysine, ubiquitin chains display an ample structural diversity, that has its counterpart in many different
Several ubiquitination events have been assoctaied to DSB signaling. As previously discussed, PIKK activation is followed by ubiquitination of various substrates. Again, ATM-dependent phosphorylation of H2AX and MDC1 are sufficient to recruit the E3 ubiquitin ligase
This coordinated cascade of UQ modifications generated at DSB is necessary for the formation of BRCA1 and 53BP1 foci. However, once again, the absence of RNF8 does not lead to major BRCA1 phenotypes, which challenges the relevance of IRIF as predictors of functionality. It should be noted also that there is no evidence of direct binding of 53BP1 to ubiquitin chains, and how UQ mediates 53BP1 foci remains a mistery. In addition, 53BP1 can bind methylated histones which may provide an independent way of loading to DSB [94, 95, 162].
In contrast to 53BP1, the relationship of BRCA1 foci with UQ is well characterized.
The UQ pathway does not end with 53BP1 or BRCA1.
To complicate things further, BRCA1 auto-ubiquitination is linked to K6, which is mediated by the E2 enzyme Ubch5c . Ubiquitinated BRCA1 is found at DSB and also in several endogenous spots during S phase. Interestingly, even though 20% of human BRCA1 mutations predisposing to breast and ovarian cancer are found in the RING domain , recent data emerging from mouse models suggest that the E3 ligase activity of BRCA1 might be unrelated to genome maintenance and its tumor suppression role [167, 168]. However, other studies [169, 170] indicate the importance of the RING domain in BRCA1 tumor suppressor function. Certainly, further work needs to be done to solve these divergent observations.
Finally, regardless of DSB there is solid evidence that UQ-mediated signaling pathways also contribute to other genome protective pathways. For instance, UQ plays a key role in the
SUMO stands for Small Ubiquitin-like modifier due to its similarities with UQ. In fact, SUMOylation is a similar process to ubiquitinylation involving E1, E2 and E3 enzymes. Importantly, very few SUMO E3 ligases exist in the mammalian proteome, which limits the search for potential ligases. In addition, SUMO E3 ligases are mostly dispensable and E2 ligases can complete the SUMOylation reaction largely by themselves. In contrast to UQ, three SUMO variants (SUMO1, SUMO2 and SUMO3 exist .
A number of SUMO roles with genome maintenance pathways have been discovered. In what regards to the DDR, two recent studies identified a SUMO-related signaling cascade that also coordinates the foci formation of BRCA1 and 53BP1 in response to DSB [175, 176]. At present,
|Unknown||FancD2||DNA Cross-link repair|
|Ubc13||H2A, H2AX||DSB signaling|
|Ubc13||H2A, H2AX||DSB signaling|
|Ubc9||BRCA1, 53BP1||DSB signaling|
Regardless of the DDR, other genome maintenance pathways are also controlled by SUMO. One example is the role of a SUMO ligase called Mms21, which is an essential component of a cohesin and condensin related complex formed by Smc5 and Smc6 . Whereas the role of this complex is far from being understood, it seems it might be important to prevent the accumulation of hemicatenates at stalled replication forks .
3.3.3. Interplay of PTMs in the DDR
Other post-translational modifications, such as methylation and acetylation, are also involved in the regulatory network of the DDR. A paradigm of multiple and interconnected PTM is found in the regulation of p53 levels, that involves a coordinated network of phosphorylation, acetylation, methylation and ubiquitination .
In the absence of DNA damage, p53 levels are kept low due to its
Another relevant example of the interplay between different PTMs in the DDR is found in histones. Indeed, post-translational modifications of histones regulate many other processes related to chromatin compaction and structure, such as replication and transcription. The best known histone modification upon DNA damage is the already described
4. Future perspectives
We have here provided a general overview of how cells signal the presence of DNA damage, and how a proper signaling is necessary to maintain a healthy genome. Still, whereas the amount of PTMs that coordinate the cellular response to DNA damage is already intimidating, it is likely that we are only seeing the tip of the iceberg. Many other targets and even PTM (ADP-rybosylation, Neddylation, N-terminal glycosylation, etc…) will probably be involved in mounting a proper DDR. Without a doubt, the fast development of massive proteomic technologies will soon provide a breathtaking picture of how cells detect, signal and repair DNA breaks; by promoting a myriad of PTMs in almost every molecule involved in the DDR.
Repair of endogenous DNA damage. Cold Spring Harb Symp Quant Biol Lindahl T. Barnes D. E. 2000 65 127 33
The DNA-damage response in human biology and disease. Nature Jackson S. P. Bartek J. 2009Oct 22; 461 7267 1071 8
Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol Dudley D. D. Chaudhuri J. Bassing C. H. Alt F. W. 2005 86 43 112
The leptotene-zygotene transition of meiosis. Annu Rev Genet Zickler D. Kleckner N. 1998 32 619 97
Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst) Mao Z. Bozzella M. Seluanov A. Gorbunova V. 2008Oct 1; 7 10 1765 71
Doherty AJ, Jackson SP. DNA repair: how Ku makes ends meet.Curr Biol 2001Nov 13;11(22):R 920 4
DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) Burma S. Chen D. J. Role-P of. D. N. A. in K. the cellular. response to. D. N. A. double-strand breaks. D. N. 2004Aug-Sep;3(8-9):909-18.
Martin IV, MacNeill SA. ATP-dependent DNA ligases.Genome Biol 2002REVIEWS3005.
Coordinated assembly of Ku and Calsou P. Delteil C. Frit P. Drouet J. Salles B. 460subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol Biol 2003Feb 7;326(1):93-103.
Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell Ma Pannicke Y. Schwarz U. Lieber K. M. R. 2002Mar 22; 108 6 781 94
Mol Cell Riballo E. Kuhne M. Rief N. Doherty A. Smith G. C. MJ Recio et. al A. pathway of. double-strand break. rejoining dependent. upon A. T. M. Artemis proteins locating. to-H gamma. foci A. X. 2004Dec 3; 16 5 715 24
Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci U S A Gu Y. Jin S. Gao Y. Weaver D. T. Alt F. W. 1997Jul 22; 94 15 8076 81
Immunol Chaudhuri J. Alt F. W. Class-switch recombination. interplay of. transcription D. N. A. deamination repair D. N. A. Nat Rev. 2004Jul; 4 7 541 52
J Clin Invest Moshous D. Pannetier C. Chasseval Rd. R. Deist Fl. F. Cavazzana-Calvo M. Romana S. et al. Partial T. lymphocyte B. immunodeficiency predisposition to. lymphoma in. patients with. hypomorphic mutations. in Artemis. 2003Feb; 111 3 381 7
Mol Cell AA Goodarzi Noon. A. T. Deckbar D. Ziv Y. Shiloh Y. Lobrich M. et al. A. T. M. signaling facilitates. repair of. D. N. A. double-strand breaks. associated with. heterochromatin 2008Jul 25; 31 2 167 77
Cell Fernandez-Capetillo O. Nussenzweig A. A. T. M. breaks into. heterochromatin Mol. 2008Aug 8; 31 3 303 4
Frequent chromosomal translocations induced by DNA double-strand breaks. Nature Richardson C. Jasin M. 2000Jun 8; 405 6787 697 700
Nat Cell Biol Jazayeri A. Falck J. Lukas C. Bartek J. Smith G. C. Lukas J. et al. A. T. M. cell cycle-dependent. regulation of. A. T. R. in response. to D. N. A. double-strand breaks. 2006Jan; 8 1 37 45
Mol Cell de Jager M. van Noort J. van Gent D. C. Dekker C. Kanaar R. Wyman C. Human Rad5. Mre is a. flexible complex. that can. tether D. N. A. ends 2001Nov; 8 5 1129 35
DNA Repair (Amst) Fernandez-Capetillo O. Lee A. Nussenzweig M. Nussenzweig A. H. A. X. the histone. guardian of. the genome. D. N. 2004Aug-Sep;3(8-9):959-67.
Cell Stucki M. Clapperton J. A. Mohammad D. Yaffe M. B. Smerdon S. J. Jackson S. P. M. D. C. directly binds. phosphorylated histone. H. A. X. to regulate. cellular responses. to D. N. A. double-strand breaks. 2005Dec 29; 123 7 1213 26
Mol Cell Lou Z. Minter-Dykhouse K. Franco S. Gostissa M. MA Rivera Celeste. A. et al. M. D. C. maintains genomic. stability by. participating in. the amplification. of A. T. M-dependent D. N. A. damage signals. 2006Jan 20; 21 2 187 200
Cell Mailand N. Bekker-Jensen S. Faustrup H. Melander F. Bartek J. Lukas C. et al. R. N. F. ubiquitylates histones. at D. N. A. double-strand breaks. promotes assembly. of repair. proteins 2007Nov 30; 131 5 887 900
Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J Exp Med May 10; MA Santos Huen. MS Jankovic M. Chen H. T. Lopez-Contreras A. J. Klein I. A. et al. 207 5 973 81
Cell Doil C. Mailand N. Bekker-Jensen S. Menard P. Larsen D. H. Pepperkok R. et al. R. N. F1 binds amplifies ubiquitin. conjugates on. damaged chromosomes. to allow. accumulation of. repair proteins. 2009Feb 6; 136 3 435 46
Cell Stewart G. S. Panier S. Townsend K. Al-Hakim A. K. Kolas N. K. Miller E. S. et al. The R. I. D. D. L. E. syndrome protein. mediates a. ubiquitin-dependent signaling. cascade at. sites of. D. N. A. damage 2009Feb 6; 136 3 420 34
PLoS Genet Apr;7(4):e1001381. Bohgaki T. Bohgaki M. Cardoso R. Panier S. Zeegers D. Li L. et al. Genomic instability. defective spermatogenesis. immunodeficiency cancer in. a. mouse model. of the. R. I. D. D. L. E. syndrome P. Lo
Proc Natl Acad Sci U S A Wang B. Elledge S. J. Ubc1 Rnf ubiquitin. ligases control. foci formation. of the. Rap8 Abraxas Brca. Brcc complex in. response to. D. N. A. damage 2007Dec 26; 104 52 20759 63
Fackenthal JD, Olopade OI.Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007Dec; 7 12 937 48
J Biol Chem Hashizume R. Fukuda M. Maeda I. Nishikawa H. Oyake D. Yabuki Y. et al. The R. I. N. G. heterodimer B. R. C. A. is B. A. R. D. ubiquitin a. ligase inactivated. by a. breast cancer-derived. mutation 2001May 4; 276 18 14537 40
Cell Cycle Fernandez-Capetillo O. Celeste A. Nussenzweig A. Focusing on. foci H. A. X. the recruitment. of D. N. A-damage response. factors 2003Sep-Oct; 2 5 426 7
The 3’ to 5’ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol Cell Paull T. T. Gellert M. 1998Jun; 1 7 969 79
Proc Natl Acad Sci U S A Nimonkar A. V. Ozsoy A. Z. Genschel J. Modrich P. Kowalczykowski S. C. Human exonuclease. . helicase B. L. M. interact to. resect D. N. A. initiate D. N. A. repair 2008Nov 4; 105 44 16906 11
Nature AA Sartori Lukas. C. Coates J. Mistrik M. Fu S. Bartek J. et al. Human Ct. I. P. promotes D. N. A. end resection. 2007Nov 22; 450 7169 509 14
Mol Cell You Z. Shi L. Z. Zhu Q. Wu P. Zhang Y. W. Basilio A. et al. Ct I. P. links D. N. A. double-strand break. sensing to. resection 2009Dec 25; 36 6 954 69
J Exp Med Cuadrado M. Martinez-Pastor B. Murga M. Toledo L. I. Gutierrez-Martinez P. Lopez E. et al. A. T. M. regulates A. T. R. chromatin loading. in response. to D. N. A. double-strand breaks. 2006Feb 20; 203 2 297 303
Adams KE, Medhurst AL, Dart DA, Lakin ND. Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.Oncogene 2006Jun 29; 25 28 3894 904
Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J Biol Chem Myers J. S. Cortez D. 2006Apr 7; 281 14 9346 50
Cell Apr 16; Bunting S. F. Callen E. Wong N. Chen H. T. Polato F. Gunn A. et al. . inhibits B. P. homologous recombination. in Brca1-deficient. cells by. blocking resection. of D. N. A. breaks 141 2 243 54
Mol Cell Cao L. Xu X. Bunting S. F. Liu J. Wang R. H. Cao L. L. et al. A. selective requirement. for . in B. P. the biological. response to. genomic instability. induced by. Brca deficiency. 2009Aug 28; 35 4 534 41
Cell Baumann P. Benson F. E. West S. C. Human Rad. protein promotes. A. T. P-dependent homologous. pairing strand transfer. reactions in. vitro 1996Nov 15; 87 4 757 66
BRCA2-dependent and independent formation of RAD51 nuclear foci. Oncogene Tarsounas M. Davies D. West S. C. B. R. C. 2003Feb 27; 22 8 1115 23
Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood Wagner J. E. Tolar J. Levran O. Scholl T. Deffenbaugh A. Satagopan J. et al. 2004Apr 15; 103 8 3226 9
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell Garcia-Higuera I. Taniguchi T. Ganesan S. MS Meyn Timmers. C. Hejna J. et al. 2001Feb; 7 2 249 62
Mol Cell MJ Mc Ilwraith Vaisman. A. Liu Y. Fanning E. Woodgate R. West S. C. Human D. N. A. polymerase eta. promotes D. N. A. synthesis from. strand invasion. intermediates of. homologous recombination. 2005Dec 9; 20 5 783 92
The Induction of Mitotic Recombination by Mitomycin C in Ustilago and Saccharomyces. Genetics Holliday R. 1964Sep; 50 323 35
Double Holliday junctions are intermediates of DNA break repair. Nature Apr 8; Bzymek M. Thayer N. H. Oh S. D. Kleckner N. Hunter N. 464 7290 937 41
The Bloom’s syndrome helicase suppresses crossing over during homologous recombination. Nature Wu L. Hickson I. D. 2003Dec 18; 426 6968 870 4
Human Mus81-associated endonuclease cleaves Holliday junctions in vitro. Mol Cell Chen X. B. Melchionna R. Denis C. M. Gaillard P. H. Blasina A. Van de Weyer I. et al. 2001Nov; 8 5 1117 27
Holliday junction resolution in human cells: two junction endonucleases with distinct substrate specificities. EMBO J Constantinou A. Chen X. B. Mc Gowan C. H. West S. C. 2002Oct 15; 21 20 5577 85
Svendsen JM, Harper JW. GEN1/Yen1 and the SLX4 complex: Solutions to the problem of Holliday junction resolution.Genes Dev Mar 15; 24 6 521 36
Cell Fekairi S. Scaglione S. Chahwan C. Taylor E. R. Tissier A. Coulon S. et al. Human S. L. X. is a. Holliday junction. resolvase subunit. that binds. multiple D. N. A. repair/recombination endonucleases. 2009Jul 10; 138 1 78 89
Cell Svendsen J. M. Smogorzewska A. ME Sowa O’Connell. B. C. Gygi S. P. Elledge S. J. et al. Mammalian B. T. B. D1 assembles S. L. X. Holliday a. junction resolvase. is required. for D. N. A. repair 2009Jul 10; 138 1 63 77
Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis Mar 29. Helleday T.
Genes Dev2004 Aug 15; Andreassen P. R. D’Andrea A. D. Taniguchi T. A. T. R. couples F. A. N. C. D. monoubiquitination to. the D. N. A-damage response. 18 1958 16 1958 63
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev Tibbetts R. S. Cortez D. Brumbaugh K. M. Scully R. Livingston D. Elledge S. J. et al. 2000Dec 1; 14 23 2989 3002
Phosphorylation of the Bloom’s syndrome helicase and its role in recovery from S-phase arrest. Mol Cell Biol Davies S. L. North P. S. Dart A. Lakin N. D. Hickson I. D. 2004Feb; 24 3 1279 91
Henson JD, Neumann AA, Yeager TR, Reddel RR.Alternative lengthening of telomeres in mammalian cells. Oncogene 2002Jan 21; 21 4 598 610
Harper JW, Elledge SJ. The DNA damage response: ten years after. MolCell 2007Dec 14; 28 5 739 45
Nat Rev Cancer Shiloh Y. A. T. M. related protein. kinases safeguarding. genome integrity. 2003Mar; 3 3 155 68
Common mechanisms of PIKK regulation. DNA Repair (Amst) CA Lovejoy Cortez. D. 2009Sep 2; 8 9 1004 8
Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.Nat Rev Mol Cell Biol 2008Oct; 9 10 759 69
Science Matsuoka S. BA Ballif Smogorzewska. A. Mc Donald E. R. 3rd Hurov K. E. Luo J. et al. A. T. M. substrate A. T. R. analysis reveals. extensive protein. networks responsive. to D. N. A. damage 2007May 25; 316 5828 1160 6
Science Zou L. Elledge S. J. Sensing D. N. A. damage through. A. T. R. I. P. recognition of. R. P. A-ss D. N. A. complexes 2003Jun 6; 300 5625 1542 8
Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol Cell Callen E. Jankovic M. Wong N. Zha S. Chen H. T. Difilippantonio S. et al. 2009May 15; 34 3 285 97
Science Savitsky K. Bar-Shira A. Gilad S. Rotman G. Ziv Y. Vanagaite L. et al. A. single ataxia. telangiectasia gene. with a. product similar. to P. I. kinase 1995Jun 23; 268 5218 1749 53
Found Ser Boder E. Ataxia-telangiectasia an. overview Kroc. 1985 19 1 63
The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci Shiloh Y. 2006Jul; 31 7 402 10
Requirement of the MRN complex for ATM activation by DNA damage. EMBO J Uziel T. Lerenthal Y. Moyal L. Andegeko Y. Mittelman L. Shiloh Y. 2003Oct 15; 22 20 5612 21
Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.Nature 2003Jan 30; 421 6922 499 506
Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J Cell Biol Daniel J. A. Pellegrini M. Lee J. H. Paull T. T. Feigenbaum L. Nussenzweig A. 2008Dec 1; 183 5 777 83
Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Pellegrini M. Celeste A. Difilippantonio S. Guo R. Wang W. Feigenbaum L. et al. Nature2006Sep 14; 443 7108 222 5
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol Difilippantonio S. Celeste A. Fernandez-Capetillo O. Chen H. T. Reina San. Martin B. Van Laethem F. et al. 2005Jul; 7 7 675 85
Mol Cell Biol Sun Y. Xu Y. Roy K. BD Price D. N. A. damage-induced acetylation. of lysine. 30 of A. T. M. activates A. T. M. kinase activity. 2007Dec; 27 24 8502 9
Lavin MF. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.Oncogene 2007Dec 10; 26 56 7749 58
Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet Matsuura S. Tauchi H. Nakamura A. Kondo N. Sakamoto S. Endo S. et al. 1998Jun; 19 2 179 81
Cell Stewart G. S. Maser R. S. Stankovic T. Bressan D. A. Kaplan M. I. Jaspers N. G. et al. The D. N. A. double-strand break. repair gene. h. M. R. E. is mutated. in individuals. with an. ataxia-telangiectasia-like disorder. 1999Dec 10; 99 6 577 87
Proc Natl Acad Sci U S A Barlow C. Ribaut-Barassin C. Zwingman T. A. Pope A. J. Brown K. D. Owens J. W. et al. A. T. M. is a. cytoplasmic protein. in mouse. brain required. to prevent. lysosomal accumulation. 2000Jan 18; 97 2 871 6
DNA replication by ATR: signaling in response to DNA intermediates. DNA Repair (Amst) Shechter D. Costanzo V. Gautier J. Regulation of. D. N. A. replication by. A. T. R. signaling in. response to. D. N. A. intermediates D. N. 2004Aug-Sep;3(8-9):901-8.
DNA damage. DNA Repair (Amst) Dec 10; Lopez-Contreras A. J. Fernandez-Capetillo O. The A. T. R. barrier to. replication-born D. N. A. damage D. N. 9 12 1249 55
Genes Dev Brown E. J. Baltimore D. A. T. R. disruption leads. to chromosomal. fragmentation early embryonic. lethality 2000Feb 15; 14 4 397 402
Nat Genet O’Driscoll M. Ruiz-Perez V. L. Woods C. G. Jeggo P. A. Goodship J. A. A. splicing mutation. affecting expression. of ataxia-telangiectasia. Rad3-related protein. . A. T. R. results in. Seckel syndrome. 2003Apr; 33 4 497 501
Nat Rev Mol Cell Biol Cimprich K. A. Cortez D. A. T. R. an essential. regulator of. genome integrity. 2008Aug; 9 8 616 27
Nucleic Acids Res Fanning E. Klimovich V. Nager A. R. A. dynamic model. for replication. protein A. . R. P. A. function in. D. N. A. processing pathways. 2006 34 15 4126 37
Science Cortez D. Guntuku S. Qin J. Elledge S. J. A. T. R. partners A. T. R. I. P. in checkpoint. signaling 2001Nov 23; 294 5547 1713 6
Methods Enzymol Yang X. H. Zou L. Recruitment-A of. A. T. R. Rad1 T. R. I. P. 9-1 complexes to. D. N. A. damage 2006 409 118 31
J, Kumagai A, Dunphy WG. The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. J Biol Chem Lee J. Kumagai A. Dunphy W. G. The Rad. Hus Rad checkpoint. clamp regulates. interaction of. Top B. P. with A. T. R. 2007Sep 21; 282 38 28036 44
Cell Kumagai A. Lee J. Yoo H. Y. Dunphy W. G. Top B. P. activates-A the. A. T. R. complex T. R. I. P. 2006Mar 10; 124 5 943 55
Genes Dev Toledo L. I. Murga M. Gutierrez-Martinez P. Soria R. Fernandez-Capetillo O. A. T. R. signaling can. drive cells. into senescence. in the. absence of. D. N. A. breaks 2008Feb 1; 22 3 297 302
Nat Cell Biol Celeste A. Fernandez-Capetillo O. MJ Kruhlak Pilch. D. R. Staudt D. W. Lee A. et al. Histone H. A. X. phosphorylation is. dispensable for. the initial. recognition of. D. N. A. breaks 2003Jul; 5 7 675 9
Nat Cell Biol Fernandez-Capetillo O. Chen H. T. Celeste A. Ward I. Romanienko P. J. Morales J. C. et al. D. N. A. damage-induced G. checkpoint M. activation by. histone H. A. X. . B. P. 2002Dec; 4 12 993 7
Cell MS Huen Grant. R. Manke I. Minn K. Yu X. Yaffe M. B. et al. R. N. F. transduces the. D. N. A-damage signal. via histone. ubiquitylation checkpoint protein. assembly 2007Nov 30; 131 5 901 14
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science Kolas N. K. Chapman J. R. Nakada S. Ylanko J. Chahwan R. Sweeney F. D. et al. 2007Dec 7; 318 5856 1637 40
Nature Huyen Y. Zgheib O. Ditullio R. A. Jr Gorgoulis V. G. Zacharatos P. Petty T. J. et al. Methylated lysine. . of histone. H. targets . to B. P. double-strand D. N. A. breaks 2004Nov 18; 432 7015 406 11
Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell Botuyan M. V. Lee J. Ward I. M. Kim J. E. Thompson J. R. Chen J. et al. 2006Dec 29; 127 7 1361 73
Genomic instability in mice lacking histone H2AX. Science Celeste A. Petersen S. Romanienko P. J. Fernandez-Capetillo O. Chen H. T. Sedelnikova O. A. et al. 2002May 3; 296 5569 922 7
Molina JR, Yu X, et al. 53BP1 cooperates with Ward I. M. Difilippantonio S. Minn K. MD Mueller Molina. J. R. Yu X. et al. . cooperates B. P. with p. as functions a. haploinsufficient tumor. suppressor in. mice 53and functions as a haploinsufficient tumor suppressor in mice. Mol Cell Biol 2005Nov;25(22):10079-86.
Ataxia-telangiectasia mutated (ATM)-dependent activation of ATR occurs through phosphorylation of TopBP1 by ATM. J Biol Chem Yoo H. Y. Kumagai A. Shevchenko A. Dunphy W. G. 2007Jun 15; 282 24 17501 6
Mol Cell Kumagai A. Dunphy W. G. Claspin a. novel protein. required for. the activation. of Chk. during a. D. N. A. replication checkpoint. response in. Xenopus egg. extracts 2000Oct; 6 4 839 49
Stabilizers and destabilizers controlling cell cycle oscillators. Mol Cell Guardavaccaro D. Pagano M. 2006Apr 7; 22 1 1 4
Abraham RT.Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev2001Sep 1; 15 17 2177 96
Cancer Cell Bartek J. Lukas J. Chk Chk kinases. in checkpoint. control cancer 2003May; 3 5 421 9
Smits VA, Reaper PM, Jackson SP.Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 2006Jan 24; 16 2 150 9
Genes Dev Jin J. Shirogane T. Xu L. Nalepa G. Qin J. Elledge S. J. et al. S. C. Fbeta-T R. C. P. links Chk. signaling to. degradation of. the Cdc. protein A. phosphatase 2003Dec 15; 17 24 3062 74
J, Rosenberg SH, Fesik S, et al. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem Xiao Z. Chen Z. Gunasekera A. H. Sowin T. J. Rosenberg S. H. Fesik S. et al. Chk mediates. S. arrests G. through Cdc. degradation A. in response. to D. N. A-damaging agents. 2003Jun 13; 278 24 21767 73
The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol Boutros R. Dozier C. Ducommun B. 2006Apr; 18 2 185 91
Activation of the ATM kinase by ionizing radiation and phosphorylation of CE Canman Lim. DS Cimprich K. A. Taya Y. Tamai K. Sakaguchi K. et al. 53Science 1998Sep 11;281(5383):1677-9.
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate Shieh S. Y. Ahn J. Tamai K. Taya Y. Prives C. 53at multiple DNA damage-inducible sites. Genes Dev 2000Feb 1;14(3):289-300.
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene Geng Y. Eaton E. N. Picon M. Roberts J. M. AS Lundberg Gifford. A. et al. 1996Mar 21; 12 6 1173 80
Nature Falck J. Mailand N. Syljuasen R. G. Bartek J. Lukas J. The-Chk A. T. M. Cdc checkpoint A. pathway guards. against radioresistant. D. N. A. synthesis 2001Apr 12; 410 6830 842 7
Rapid destruction of human Cdc25A in response to DNA damage. Science Mailand N. Falck J. Lukas C. Syljuasen R. G. Welcker M. Bartek J. et al. 2000May 26; 288 5470 1425 9
FEBS Lett Bartek J. Lukas J. Pathways governing. G. transition S. their response. to D. N. A. damage F. E. B. 2001Feb 16; 490 3 117 22
Arias EE, Walter JC. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells.Genes Dev 2007Mar 1; 21 5 497 518
Taylor WR, Stark GR.Regulation of the G2/M transition by 53 Oncogene2001Apr 5;20(15):1803-15.
The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res Hayflick L. 1965Mar; 37 614 36
Harley CB, Futcher AB, Greider CW.Telomeres shorten during ageing of human fibroblasts. Nature 1990May 31; 345 6274 458 60
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol Parrinello S. Samper E. Krtolica A. Goldstein J. Melov S. Campisi J. 2003Aug; 5 8 741 7
Oncogenic ras provokes premature cell senescence associated with accumulation of Serrano M. Lin A. W. ME Mc Currach Beach. D. Lowe S. W. 53and p16INK4a. Cell 1997Mar 7;88(5):593-602.
Premature senescence involving Lin A. W. Barradas M. Stone J. C. van Aelst L. Serrano M. Lowe S. W. 53and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998Oct 1;12(19):3008-19.
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature Michaloglou C. Vredeveld L. C. MS Soengas Denoyelle. C. Kuilman T. van der Horst C. M. et al. B. R. A. F. 2005Aug 4; 436 7051 720 4
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev Zhu J. Woods D. Mc Mahon M. Bishop J. M. 1998Oct 1; 12 19 2997 3007
Nature d’Adda di Fagagna. F. Reaper P. M. Clay-Farrace L. Fiegler H. Carr P. Von Zglinicki. T. et al. A. D. N. A. damage checkpoint. response in. telomere-initiated senescence. 2003Nov 13; 426 6963 194 8
Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res Martens U. M. Chavez E. A. Poon S. S. Schmoor C. Lansdorp P. M. 2000Apr 10; 256 1 291 9
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature Bartkova J. Rezaei N. Liontos M. Karakaidos P. Kletsas D. Issaeva N. et al. 2006Nov 30; 444 7119 633 7
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature Di Micco R. Fumagalli M. Cicalese A. Piccinin S. Gasparini P. Luise C. et al. 2006Nov 30; 444 7119 638 42
Genes Dev Mallette F. A. Gaumont-Leclerc M. F. Ferbeyre G. The D. N. A. damage signaling. pathway is. a. critical mediator. of oncogene-induced. senescence 2007Jan 1; 21 1 43 8
Science Halazonetis T. D. Gorgoulis V. G. Bartek J. An oncogene-induced. D. N. A. damage model. for cancer. development 2008Mar 7; 319 5868 1352 5
Carcinogenesis Serrano M. The I. N. K4a A. R. F. locus in. murine tumorigenesis. 2000May; 21 5 865 9
The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci Pollack M. Phaneuf S. Dirks A. Leeuwenburgh C. 2002Apr; 959 93 107
Cell Miyashita T. Reed J. C. Tumor suppressor. p. is a. direct transcriptional. activator of. the human. bax gene. 1995Jan 27; 80 2 293 9
Mol Cell Nakano K. Vousden K. H. P. U. M. A. a. novel proapoptotic. gene is. induced by. p5 2001Mar; 7 3 683 94
Science Oda E. Ohki R. Murasawa H. Nemoto J. Shibue T. Yamashita T. et al. Noxa a. B. H3-only member. of the. Bcl family candidate mediator. of p53-induced. apoptosis 2000May 12; 288 5468 1053 8
Martinou JC, Green DR.Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001Jan; 2 1 63 7
Organelle-specific initiation of cell death pathways. Nat Cell Biol Ferri K. F. Kroemer G. 2001Nov;3(11):E 255 63
Aging and cancer cell biology, 2007. Aging Campisi J. Cell2007Jun; 6 3 261 3
Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell Inomata K. Aoto T. Binh N. T. Okamoto N. Tanimura S. Wakayama T. et al. 2009Jun 12; 137 6 1088 99
The non-apoptotic role of Tedeschi A. Di Giovanni S. 53in neuronal biology: enlightening the dark side of the moon. EMBO Rep 2009Jun;10(6):576-83.
The tumor suppressor Cicalese A. Bonizzi G. CE Pasi Faretta. M. Ronzoni S. Giulini B. et al. 53regulates polarity of self-renewing divisions in mammary stem cells. Cell 2009Sep 18;138(6):1083-95.
Cell Budanov A. V. Karin M. p. target genes. sestrin sestrin connect. genotoxic stress. signaling m. T. O. R. 2008Aug 8; 134 3 451 60
Proc Natl Acad Sci U S A Mar 2; Alexander A. Cai S. L. Kim J. Nanez A. Sahin M. Mac Lean. K. H. et al. A. T. M. signals to. T. S. C. in the. cytoplasm to. regulate m. T. O. R. C. in response. to R. O. S. 107 9 4153 8
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature Gorgoulis V. G. Vassiliou L. V. Karakaidos P. Zacharatos P. Kotsinas A. Liloglou T. et al. 2005Apr 14; 434 7035 907 13
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature Braig M. Lee S. Loddenkemper C. Rudolph C. Peters A. H. Schlegelberger B. et al. 2005Aug 4; 436 7051 660 5
Nature Collado M. Gil J. Efeyan A. Guerra C. Schuhmacher A. J. Barradas M. et al. Tumour biology. senescence in. premalignant tumours. 2005Aug 4;436(7051):642.
Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol Lord C. J. Ashworth A. 2008Aug; 8 4 363 9
Int J Cancer Chen Z. Xiao Z. Gu W. Z. Xue J. Bui M. H. Kovar P. et al. Selective Chk. inhibitors differentially. sensitize p53-deficient. cancer cells. to cancer. therapeutics 2006Dec 15; 119 12 2784 94
Nat Genet Murga M. Bunting S. Montana M. F. Soria R. Mulero F. Canamero M. et al. A. mouse model. of-Seckel A. T. R. shows embryonic. replicative stress. accelerated aging. 2009Aug; 41 8 891 8
Toledo L. I. Murga M. Zur R. Soria R. Rodriguez A. Martinez S. et al. A. cell-based screen. identifies A. T. R. inhibitors with. synthetic lethal. properties for. cancer-associated mutations.
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol Dec; Murga M. Campaner S. Lopez-Contreras A. J. Toledo L. I. Soria R. Montana M. F. et al. 18 12 1331 5
DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol Garinis G. A. van der Horst G. T. Vijg J. Hoeijmakers J. H. D. N. 2008Nov; 10 11 1241 7
Cell Lombard D. B. Chua K. F. Mostoslavsky R. Franco S. Gostissa M. Alt F. W. D. N. A. repair genome. stability aging 2005Feb 25; 120 4 497 512
Nature Rossi D. J. Bryder D. Seita J. Nussenzweig A. Hoeijmakers J. Weissman I. L. Deficiencies in. D. N. A. damage repair. limit the. function of. haematopoietic stem. cells with. age 2007Jun 7; 447 7145 725 9
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol Sedelnikova O. A. Horikawa I. Zimonjic D. B. Popescu N. C. Bonner W. M. Barrett J. C. 2004Feb; 6 2 168 70
Rossi DJ, Jamieson CH, Weissman IL.Stems cells and the pathways to aging and cancer. Cell 2008Feb 22; 132 4 681 96
Intrauterine programming of ageing. EMBO Rep Jan; Fernandez-Capetillo O. 11 1 32 6
Pickart CM.Ubiquitin enters the new millennium. Mol Cell 2001Sep; 8 3 499 504
Ubiquitylation and cell signaling. EMBO J Haglund K. Dikic I. 2005Oct 5; 24 19 3353 9
Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol Schwartz A. L. Ciechanover A. 2009 49 73 96
Pickart CM, Cohen RE.Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 2004Mar; 5 3 177 87
Messick TE, Greenberg RA.The ubiquitin landscape at DNA double-strand breaks. J Cell Biol 2009Nov 2; 187 3 319 26
Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. Chem Rev Grabbe C. Dikic I. 2009Apr; 109 4 1481 94
Nat Cell Biol Jan;12(1):80-6; sup Bekker-Jensen S. Rendtlew Danielsen. J. Fugger K. Gromova I. Nerstedt A. Lukas C. et al. H. E. R. C. coordinates ubiquitin-dependent. assembly of. D. N. A. repair factors. on damaged. chromosomes 1 12
Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell Sanders S. L. Portoso M. Mata J. Bahler J. Allshire R. C. Kouzarides T. 2004Nov 24; 119 5 603 14
Proc Natl Acad Sci U S A Shao G. Lilli D. R. Patterson-Fortin J. Coleman K. A. Morrissey D. E. Greenberg R. A. The Rap8. B. R. C. C. de-ubiquitinating enzyme. complex antagonizes. R. N. F. Ubc13-dependent ubiquitination. events at. D. N. A. double strand. breaks 2009Mar 3; 106 9 3166 71
Genes Dev Shao G. Patterson-Fortin J. Messick T. E. Feng D. Shanbhag N. Wang Y. et al. M. E. R. I. T. controls B. R. C. A. Rap complex integrity. recruitment to. D. N. A. double-strand breaks. 2009Mar 15; 23 6 740 54
Genes Dev Yu X. Fu S. Lai M. Baer R. Chen J. B. R. C. A. ubiquitinates its. phosphorylation-dependent binding. partner Ct. I. P. 2006Jul 1; 20 13 1721 6
Mol Cell Brzovic P. S. Lissounov A. Christensen D. E. Hoyt D. W. Klevit R. E. A. Ubc H5/ubiquitin. noncovalent complex. is required. for processive. B. R. C. A1-directed ubiquitination. 2006Mar 17; 21 6 873 80
Proc Natl Acad Sci U S A Reid L. J. Shakya R. Modi A. P. Lokshin M. Cheng J. T. Jasin M. et al. E. ligase activity. of B. R. C. A. is not. essential for. mammalian cell. viability or. homology-directed repair. of double-strand. D. N. A. breaks 2008Dec 30; 105 52 20876 81
Science Oct 28; Shakya R. Reid L. J. Reczek C. R. Cole F. Egli D. Lin C. S. et al. B. R. C. A. tumor suppression. depends on. B. R. C. T. phosphoprotein binding. but not. its E. ligase activity. 334 6055 525 8
Cancer Cell Dec 13; Drost R. Bouwman P. Rottenberg S. Boon U. Schut E. Klarenbeek S. et al. B. R. C. A. R. I. N. G. function is. essential for. tumor suppression. but dispensable. for therapy. resistance 20 6 797 809
Nature Sep 8; Zhu Q. Pao G. M. Huynh A. M. Suh H. Tonnu N. Nederlof P. M. et al. B. R. C. A. tumour suppression. occurs via. heterochromatin-mediated silencing. 477 7363 179 84
Moldovan GL, D’Andrea AD.How the fanconi anemia pathway guards the genome. Annu Rev Genet 2009 43 223 49
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet Wang W. 2007Oct; 8 10 735 48
Mol Cell Matsushita N. Kitao H. Ishiai M. Nagashima N. Hirano S. Okawa K. et al. A. Fanc D2-monoubiquitin. fusion reveals. hidden functions. of Fanconi. anemia core. complex in. D. N. A. repair 2005Sep 16; 19 6 841 7
Yeh ET. SUMOylation and De-SUMOylation: wrestling with life’s processes.J Biol Chem 2009Mar 27; 284 13 8223 7
Nature Galanty Y. Belotserkovskaya R. Coates J. Polo S. Miller K. M. Jackson S. P. Mammalian S. U. M. O. E3-ligases P. I. A. S. promote P. I. A. S. responses to. D. N. A. double-strand breaks. 2009Dec 17; 462 7275 935 9
Nature Morris J. R. Boutell C. Keppler M. Densham R. Weekes D. Alamshah A. et al. The S. U. M. O. modification pathway. is involved. in the. B. R. C. A. response to. genotoxic stress. 2009Dec 17; 462 7275 886 90
Potts PR.The Yin and Yang of the MMS21-SMC5/6 SUMO ligase complex in homologous recombination. DNA Repair (Amst) 2009Apr 5; 8 4 499 506
Cell Branzei D. Sollier J. Liberi G. Zhao X. Maeda D. Seki M. et al. Ubc mms21-mediated sumoylation. counteracts recombinogenic. events at. damaged replication. forks 2006Nov 3; 127 3 509 22
Lessons from interconnected ubiquitylation and acetylation of Benkirane M. Sardet C. Coux O. 53think metastable networks. Biochem Soc Trans Feb;38(Pt 1):98-103.
Cell Momand J. Zambetti G. P. Olson D. C. George D. Levine A. J. The mdm. oncogene product. forms a. complex with. the p. protein inhibits p53-mediated. transactivation 1992Jun 26; 69 7 1237 45
EMBO J Ito A. Lai C. H. Zhao X. Saito S. Hamilton M. H. Appella E. et al. p30 P-mediated C. B. p. acetylation is. commonly induced. by p53-activating. agents inhibited by. M. D. M. E. M. B. 2001Mar 15; 20 6 1331 40
Mol Cell Shi X. Kachirskaia I. Yamaguchi H. West L. E. Wen H. Wang E. W. et al. Modulation of. p. function by. S. E. T8-mediated methylation. at lysine. 38 2007Aug 17; 27 4 636 46
Methylation-acetylation interplay activates Ivanov G. S. Ivanova T. Kurash J. Ivanov A. Chuikov S. Gizatullin F. et al. 53in response to DNA damage. Mol Cell Biol 2007Oct;27(19):6756-69.
Tjeertes JV, Miller KM, Jackson SP.Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J2009Jul 8; 28 13 1878 89
Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol van Attikum H. Gasser S. M. 2009May; 19 5 207 17
Cell Cycle Yuan J. Pu M. Zhang Z. Lou Z. Histone H. K. acetylation is. important for. genomic stability. in mammals. 2009Jun 1; 8 11 1747 53
Why cells respond differently to DNA damage: a chromatin perspective. Cell Cycle Fernandez-Capetillo O. Murga M. 2008Apr 15; 7 8 980 3